13F-HR filed by Jones Hill Capital LP
Jones Hill Capital LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-14, with 26 holding rows worth $466,471,290.
- Accession
- 0002102314-26-000003
- Filer
- CIK 2102314
- Filed
- 2026-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 26 entries on the cover page, a total value of $466,471,290 stated on the cover page (in dollars after the unit check, H1), rows summing to $466,471,290 with VALUE read as dollars as filed, 13F file number 028-26921. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 1,268,390 | $71,651,351 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 108,603 | $48,495,584 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 644,831 | $37,471,129 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 300,830 | $30,820,034 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 909,207 | $27,639,893 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 521,237 | $27,479,615 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 1,260,136 | $25,064,105 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 318,591 | $24,499,648 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 1,165,557 | $24,418,419 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 593,040 | $23,247,168 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 1,598,794 | $22,223,237 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 25,995 | $18,982,849 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,771,926 | $13,590,672 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 1,198,213 | $10,735,988 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 2,383,031 | $10,223,203 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 140,843 | $6,908,349 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 513,053 | $6,700,472 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 100,843 | $6,368,235 | dollars as filed | |
| TONIX PHARMACEUTICALS HOLDIN | 890260839 | COMMON STOCK | 452,116 | $6,216,595 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 100,593 | $4,848,583 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 374,010 | $4,720,006 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 167,014 | $4,718,146 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 370,175 | $4,416,188 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 342,752 | $2,385,554 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 301,604 | $1,589,453 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 45,809 | $1,056,814 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002102314-26-000003 | this filing | 2026-05-14 | acceptance time not in the bulk data set |